| HOME >> MEDICINE >> TECHNOLOGY |
Sales in Thousand Units for years 2009 through 2017
(includes corresponding Graph/Chart) 85
Table 32: US Historic Review for Coronary Stents by Product
Segment - Bare Metal and Drug Eluting Stent Markets
Independently Analyzed with Annual Sales in US$ Million for
years 2003 through 2008 (includes corresponding Graph/Chart) 86
Table 33: US Historic Review for Coronary Stents by Product
Segment - Bare Metal and Drug Eluting Stent Markets
Independently Analyzed with Annual Sales in Thousand Units
for years 2003 through 2008 (includes corresponding
Graph/Chart) 87
Table 34: US 15-Year Perspective for Coronary Stents by
Product Segment - Percentage Breakdown of Dollar Sales for
Bare Metal Stents and Drug Eluting Stents Markets for years
2003, 2010 & 2017 (includes corresponding Graph/Chart) 88
Table 35: US 15-Year Perspective for Coronary Stents by
Product Segment - Percentage Breakdown of Unit Sales for
Bare Metal Stents and Drug Eluting Stents Markets for years
2003, 2010 & 2017 (includes corresponding Graph/Chart) 89
14. JAPAN 90
A.Market Analysis 90
Prospects Weighed down by Regulatory Entanglements 90
Japanese Coronary Stents Command Higher Prices 90
Table 36: Coronary Stent Pricing (2008): Comparative
Analysis of Prices in Japan, US, Europe and Global Average
(includes corresponding Graph/Chart) 90
Competitive Landscape 91
Table 37: Leading Players in the Japanese Coronary Stent
Market ( 2010) - Percentage Breakdown of Share for Johnson &
Johnson, Medtronic, Boston Scientific, and Others
(includes corresponding Graph/Chart) 91
Table 38: Leading Players in the Japanese Bare Metal Stent
Market (2010) - Percentage Breakdown by of Share for
Medtronic, Boston Scientific
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |